Volume 9, Number 8—August 2003
Research
Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence
Table 1
Genesb | CA-MRSA isolates from | |||||
---|---|---|---|---|---|---|
France- Switzerlandc n=67 (%) | USA n=29 (%) | USA n=4 (%) | Oceaniad Southwest Pacific clone n=13 (%) | Australia Queensland clone n=4 (%) | Total n=117 (%) | |
Sequence type | 80 | 1 | 59 or 8 | 30 | 93 | |
PFGE pattern | A1-7 | B1-5 | D1 & F1 | C1-3 | E1 | |
agr type | 3 | 3 | 1 | 3 | 3 | |
SCCmec type IVa | 67 (100) | 29 (100) | 4 (100) | 13 (100) | 4 (100) | 117 (100) |
Leukocidins PVL genes | 67 (100) | 29 (100) | 4 (100) | 13 (100) | 4 (100) | 117 (100) |
lukE-lukD | 67 (100) | 29 (100) | 3 (75) | 13 (100) | 0 (0) | 116 (99) |
Hemolysinse | ||||||
hlg | 0 (0) | 0 (0) | 0 (0) | 13 (100) | 0 (0) | 13 (11) |
hlg-v | 67 (100) | 29 (100) | 4 (100) | 0 (0) | 0 (0) | 100 (85) |
hlb | 0 (0) | 0 (0) | 1 (25) | 0 (0) | 0 (0) | 1 (1) |
Enterotoxins sea | 0 (0) | 23 (79) | 0 (0) | 0 (0) | 0 (0) | 23 (20) |
seb | 0 (0) | 8 (28) | 1 (25) | 0 (0) | 0 (0) | 9 (8) |
sec | 0 (0) | 20 (69) | 0 (0) | 0 (0) | 0 (0) | 20 (17) |
sed-sej | 0 (0) | 0 (0) | 3 (75) | 0 (0) | 0 (0) | 3 (3) |
she | 0 (0) | 29 (100) | 0 (0) | 0 (0) | 0 (0) | 29 (25) |
sek | 0 (0) | 24 (83) | 0 (0) | 0 (0) | 0 (0) | 24 (21) |
egcf | 0 (0) | 0 (0) | 0 (0) | 13 (100) | 0 (0) | 13 (11) |
aPFGE, Pulsed-field gel electrophoresis; PVL, Panton-Valentine leukocidin.
bResults for toxin genes absent from all community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates (see, tst, eta, etb, lukM, and edinA) are not presented.
cIsolates from France (61) and Switzerland (6).
dIsolates from Australia (8), New Zealand (4) and Western Samoa (1).
ehlg, γhaemolysin gene; hlg-v, γ-haemolysin variant gene; hlb, β-haemolysin gene.
fegc: enterotoxin gene cluster, which includes the seg, sei, sem, sen, and seo gene
References
- Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis. 2001;32(Suppl 2):S114–32. DOIPubMedGoogle Scholar
- Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996–1998. Clin Infect Dis. 2001;33:990–6. DOIPubMedGoogle Scholar
- Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819–24. DOIPubMedGoogle Scholar
- Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O’Brien FG, Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40:4289–94. DOIPubMedGoogle Scholar
- Adhikari RP, Cook GM, Lamont I, Lang S, Heffernan H, Smith JM. Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2002;50:825–31. DOIPubMedGoogle Scholar
- Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819–27. DOIPubMedGoogle Scholar
- Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128–32. DOIPubMedGoogle Scholar
- Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753–9. DOIPubMedGoogle Scholar
- Nimmo GR, Schooneveldt J, O’ane G, McCall B, Vickery A. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J Clin Microbiol. 2000;38:3926–31.PubMedGoogle Scholar
- Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis. 2003. In press. DOIPubMedGoogle Scholar
- Gosbell IB, Mercer JL, Neville SA, Crone SA, Chant KG, Jalaludin BB, Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med J Aust. 2001;174:627–30.PubMedGoogle Scholar
- Nimmo G, Playford E. Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust. 2003;178:245.PubMedGoogle Scholar
- Lelievre H, Lina G, Jones ME, Olive C, Forey F, Roussel-Delvallez M, Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J Clin Microbiol. 1999;37:3452–7.PubMedGoogle Scholar
- de l'Antibiogramme de le Société Française de Microbiologie C. Zone sizes and MIC breakpoints for non-fastidious organisms. Clin Microbiol Infect. 1996;2(Suppl. 1):S1–49.PubMedGoogle Scholar
- Oliveira D, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46:2155–61. DOIPubMedGoogle Scholar
- Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70:631–41. DOIPubMedGoogle Scholar
- Inoue S, Sugai M, Murooka Y, Paik SY, Hong YM, Ohgai H, Molecular cloning and sequencing of the epidermal cell differentiation inhibitor gene from Staphylococcus aureus. Biochem Biophys Res Commun. 1991;174:459–64. DOIPubMedGoogle Scholar
- Jarraud S, Peyrat MA, Lim A, Tristan A, Bes M, Mougel C, egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol. 2001;166:669–77.PubMedGoogle Scholar
- Goering RV, Winters MA. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol. 1992;30:577–80.PubMedGoogle Scholar
- Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.PubMedGoogle Scholar
- Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin- resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008–15.PubMedGoogle Scholar
- Ma XX, Ito T, Etienne J, Okuma K, Hiramatsu K. Historical distribution of SCCmec allotype in healthcare-associated MRSA strains in Japan and France. 10th International Symposium on Staphylococci and Staphylococcal Infections. Tsukuba, Japan; 2002;Oct 16–19:Abstract 299.
- Oliveira DC, Tomasz A, de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Resist. 2001;7:349–61. DOIPubMedGoogle Scholar
- Collignon P, Gosbell I, Vickery A, Nimmo G, Stylianopoulos T, Gottlieb T. Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Australian Group on Antimicrobial Resistance. Lancet. 1998;352:145–6. DOIPubMedGoogle Scholar
- Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 1998;17:745–6. DOIPubMedGoogle Scholar
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.